{
  "symbol": "MAIA",
  "company": "MAIA Biotechnology, Inc.",
  "generated_at": "2026-06-24T07:36:49.819Z",
  "event_count": 2,
  "events": [
    {
      "type": "pipeline_event",
      "ts": "2026-06-02T14:21:17.518Z",
      "stage": "scout",
      "outcome": "failed",
      "reason": null,
      "trigger": "[insider_cluster_universe] 3 Form 4 filings in last 14 days · at least one open-market P/S trade verified",
      "source": "idle_hunter"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-06-02T13:33:42.237Z",
      "summary": "MAIA is a clinical-stage oncology biotech with one lead asset — Ateganosine (THIO) — in Phase 3 for NSCLC. The investigation trigger was met: CEO Vlad Vitoc purchased $100,880 on June 1, Chief Scientific Officer bought $2,690 that same day, and Director Stan Smith bought ~$100,200 that same day; these are verified open-market P-code transactions within the last 14 days. Phase 3 trial (THIO-104) presented at ASCO 2026 with FDA Fast Track designation granted. Cash position strengthened by $33M capital raise in March-April. The stock has collapsed from a January 2026 high of ~$3.19 to ~$1.30 (~59% drawdown), creating a valuation disconnect vs. late-stage clinical momentum. No options market exists (illiquid micro-cap). The smart-money cluster is genuine and the catalyst list is strong, but the lack of revenue, negative FCF, and single-asset risk are severe anti-signals that limit conventional structure selection.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 23,
      "walltime_min": 27,
      "debug_path": "dossiers/2026-06-02-MAIA.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "MAIA",
    "call": "HOLD",
    "confidence": 2,
    "score": -2,
    "factors": {
      "below_200dma": "-2",
      "above_50dma": "+1",
      "momentum_down": "-1 (-26.4%)",
      "rsi_neutral": "0 (53.7)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (2d ago)",
      "broken_below_high": "-2 (-53.2% from high)"
    },
    "summary": "HOLD (score -2) · 12-1 mom -26.4% · RSI 53.7 · above_50_only · -53.2% from high",
    "last_close": 1.38,
    "one_month_ago_close": 1.28,
    "twelve_month_ago_close": 1.74,
    "twelve_one_momentum_pct": -26.44,
    "rsi_14": 53.7,
    "ma_stack": "above_50_only",
    "from_period_high_pct": -53.22,
    "period_high": 2.95,
    "price_targets": {
      "bear": 1.5,
      "fair": 4.95,
      "bull": 14,
      "bear_return_pct": 8.7,
      "fair_return_pct": 258.6,
      "bull_return_pct": 914.5,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 10.27,
        "target_mean": 12.135,
        "target_high": 14,
        "analyst_count": 2
      }
    },
    "generated_at": "2026-06-24T07:36:49.816Z"
  }
}